Evidence map›Paper›PMID 31516324›Full record

ReviewSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2019

Perovskite synthesis, properties and their related biochemical and industrial application.

Eman Abdul Rahman Assirey

Abstract readReview
In one paragraph

Review in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Visible-light-driven COScientific reports · 2026
    Article
  4. Article
  5. Inorganic SrMoACS omega · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. The journal of physical chemistry. C, Nanomaterials and interfaces · 2025
    Article
  10. Article
  11. Review
  12. Optimizing the Catalytic Performance of BaMolecules (Basel, Switzerland) · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Impedance Spectroscopy of Pr-Doped BaBiMaterials (Basel, Switzerland) · 2022
    Article
  19. Review
  20. Effect of rGO with BaCuORSC advances · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Eman Abdul Rahman AssireyDepartment of Chemistry, College of Science, Taibah University, Box 4744, Al-Madina Al-Munawarah 41412, Saudi Arabi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The perovskite structure is shown to be the single most versatile ceramic host. Inorganic perovskite type oxides are attractive compounds for varied applications due to its large number of compounds, they exhibit both physical and biochemical characteristics and their Nano-formulation have been utilized as catalysts in many reaction due to their sensitivity, unique long-term stability and anti-interference ability. Some perovskites materials are very hopeful applicants for the improvement of effective anodic catalysts performance. Depending Perovskite-phase metal oxides distinct variety of properties they became useful for various applications they are newly used in electrochemical sensing of alcohols, glucose, hydrogen peroxide, gases, and neurotransmitters. Perovskite organometallic halide showed efficient essential properties for photovoltaic solar cells. This review presents a full coverage of the structure, progress of perovskites and their related applications. Stress is focused particularly to different methods of perovskites properties and there related application.

Indexed as

Alcohols sensorCatalystsCeramicGlucoseNeurotransmittersOrganometallic halideSensorSolar cells

Identifiers

PMID31516324
PMCPMC6733782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.